Skip to main content
Clinical Trials/IRCT2016033118389N4
IRCT2016033118389N4
Completed
Phase 3

A clinical trial of the comparison of the effect of oral Nicorandil plus hydration with hydration alone on serum creatinine in high-risk patients after receiving contrast

Qom University of Medical Sciences and Health Services Vice chancellor0 sites128 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute renal failure.
Sponsor
Qom University of Medical Sciences and Health Services Vice chancellor
Enrollment
128
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Qom University of Medical Sciences and Health Services Vice chancellor

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria were the existence of at least one risk factor of contrast\-induced nephropathy, including 1\) Moderate systolic heart failure \[30% \< (EF) Ejection fraction \< 45%] 2\) Diabetes 3\) Age\> 75 years 4\) Moderate renal insufficiency (1/5mg/ dL\< Cr \< 2mg/ dL 5\) Hypotension (systolic blood pressure \< 90 mm Hg 6\) Anemia 7\) History of hypertension Exclusion criteria: 1\- Pregnancy and lactation 2\- Allergy to radiographic contrast 3\- Have cardiogenic shock and pulmonary edema during study 4\- emergency catheterization 5\- Serum creatinine levels\> 2 mg/dL and preexisting dialysis 6\- Exposure to contrast medium 48 h pre\- and post\-coronary angiography 7\- Receive of diuretics, N\-acetylcystein, sodium bicarbonate, Theophylline, Dopamine, Fenoldopam and NSAID’S during the study 8\- Needs to continuous hydration therapy (e.g., sepsis) 9\-severe heart failure (EF\<\=30%)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials